ORCID: https://orcid.org/0000-0001-7898-2831; Hopfner, Karl-Peter
ORCID: https://orcid.org/0000-0002-4528-8357 and Hornung, Veit
ORCID: https://orcid.org/0000-0002-4150-194X
(2024):
Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation.
In: Immunity, Vol. 57, No. 7: pp. 1482-1496
[PDF, 5MB]

Abstract
Toll-like receptor 7 (TLR7) is essential for recognition of RNA viruses and initiation of antiviral immunity. TLR7 contains two ligand-binding pockets that recognize different RNA degradation products: pocket 1 recognizes guanosine, while pocket 2 coordinates pyrimidine-rich RNA fragments. We found that the endonuclease RNase T2, along with 5′ exonucleases PLD3 and PLD4, collaboratively generate the ligands for TLR7. Specifically, RNase T2 generated guanosine 2′,3′-cyclic monophosphate-terminated RNA fragments. PLD exonuclease activity further released the terminal 2′,3′-cyclic guanosine monophosphate (2',3'-cGMP) to engage pocket 1 and was also needed to generate RNA fragments for pocket 2. Loss-of-function studies in cell lines and primary cells confirmed the critical requirement for PLD activity. Biochemical and structural studies showed that PLD enzymes form homodimers with two ligand-binding sites important for activity. Previously identified disease-associated PLD mutants failed to form stable dimers. Together, our data provide a mechanistic basis for the detection of RNA fragments by TLR7.
Item Type: | Journal article |
---|---|
Faculties: | Chemistry and Pharmacy > Department of Biochemistry Chemistry and Pharmacy > Department of Chemistry Chemistry and Pharmacy > GeneCenter Medicine > Medical Center of the University of Munich > Medical Clinic and Outpatient Clinic II (Gastroenterology, Hepatology) |
Subjects: | 500 Science > 540 Chemistry 500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine and health |
URN: | urn:nbn:de:bvb:19-epub-120214-1 |
ISSN: | 10747613 |
Language: | English |
Item ID: | 120214 |
Date Deposited: | 28. Aug 2024, 07:12 |
Last Modified: | 28. Aug 2024, 07:12 |